[1]李新刚.抗结核药物治疗所致肝损伤患者的危险因素及其治疗转归观察[J].医学信息,2019,32(03):155-157.[doi:10.3969/j.issn.1006-1959.2019.03.051]
　LI Xin-gang.Risk Factors and Treatment Outcomes of Patients with Liver Injury Caused by Anti-tuberculosis Drugs[J].Journal of Medical Information,2019,32(03):155-157.[doi:10.3969/j.issn.1006-1959.2019.03.051]
点击复制

抗结核药物治疗所致肝损伤患者的危险因素及其治疗转归观察()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
32卷
期数:
2019年03期
页码:
155-157
栏目:
药物与临床
出版日期:
2019-02-01

文章信息/Info

Title:
Risk Factors and Treatment Outcomes of Patients with Liver Injury Caused by Anti-tuberculosis Drugs
文章编号:
1006-1959（2019）03-0155-03
作者:
李新刚
（佳木斯市结核病防治院结核二内科，黑龙江 佳木斯 154002）
Author(s):
LI Xin-gang
(Department of Tuberculosis No. 2,Jiamusi Tuberculosis Control Institute,Jiamusi154002, Heilongjiang,China)
关键词:
抗结核药物; 肺结核; 肝损伤; 危险因素; 治疗转归; 痰菌阳性
Keywords:
Anti-tuberculosis drugs; Tuberculosis; Liver injury; Risk factors; Treatment outcome;  Sputum positive
分类号:
R97；R52
DOI:
10.3969/j.issn.1006-1959.2019.03.051
文献标志码:
A
摘要:
目的 探讨抗结核药物治疗所致肝损伤患者的危险因素及其治疗转归。方法 回顾性分析我院自2013年1月~2017年1月收治的1033例抗结核治疗患者的临床资料，其中158例患者发生抗结核药物所致肝损伤（DILD），统计分析所有患者性别、年龄、肝病史、酗酒、营养不良、痰菌情况。采用Logistics多因素回归分析法分析患者发生DILD的危险因素及治疗转归情况。结果 1033例抗结核治疗患者中，出现DILD为158例，发生率15.30%，年龄、肝病史、酗酒、营养不良、痰菌阳性是DILD的危险因素（P＜0.05）；158例DILD患者经治疗后，治疗成功150例（94.94%），治疗失败8例（5.06%）。结论 年龄、肝病史、酗酒、营养不良、痰菌阳性是DILD的危险因素，临床上应重点监测危险人群用药情况，及时调整治疗方案，降低DILD发生率，促使患者顺利完成化疗。
Abstract:
Objective To investigate the risk factors and treatment outcomes of patients with liver injury caused by anti-tuberculosis drugs. Methods The clinical data of 1033 anti-tuberculosis patients admitted to our hospital from January 2013 to January 2017 were retrospectively analyzed. Among them, 158 patients developed liver damage caused by anti-tuberculosis drugs (DILD), and all patients were statistically analyzed. Age, history of liver disease, alcoholism, malnutrition, and sputum. Logistics multivariate regression analysis was used to analyze the risk factors and treatment outcomes of patients with DILD. Results Among 1033 anti-tuberculosis patients, 158 cases had DILD, the incidence rate was 15.30%. Age, liver disease history, alcoholism, malnutrition, and sputum positive were risk factors for DILD (P<0.05). After treatment of 158 patients with DILD, 150 patients (94.94%) were successfully treated and 8 patients (5.06%) were treated with failure. Conclusion Age, liver disease history, alcoholism, malnutrition, and sputum positive are risk factors for DILD. Clinically, it is necessary to monitor the drug use of dangerous people, adjust the treatment plan in time, reduce the incidence of DILD, and prompt patients to successfully complete chemotherapy.

参考文献/References:


[1]聂思瑶,田文广,万克强,等.耐药肺结核患者抗结核治疗肝损伤的临床治疗[J].西部医学,2017,29(9):1285-1287.
[2]戈启,杜亚东,聂文娟.55例抗结核药物所致重度肝损伤患者的临床分析[J].中国防痨杂志,2016,38(6):504-506.
[3]陈静,李亚利,梁欣,等.96例药物性肝损伤临床特点分析及危险因素探讨[J].临床药物治疗杂志,2017,15(2):19-23.
[4]李凌未,马凌飞,李胜前.412例抗结核药物导致肝损害的临床评价分析[J].药物流行病学杂志,2016,25(12):773-776.
[5]毛佳斌,孙培英,徐金田.初治肺结核患者药物性肝损伤的危险因素分析及对策[J].中华全科医学,2016,14(11):1867-1869.
[6]何涛,汪峰,唐武.抗结核药致药物性肝损伤危险因素的Logistic回归分析[J].中国药房,2016,27(12):1626-1628.
[7]陈诗娴,周玲,陈永忠,等.住院抗结核治疗患者药物性肝炎发生及转归研究[J].中华流行病学杂志,2016,37(7):930-934.

相似文献/References:

[1]刘德福.肺结核患者痰中结核分枝杆菌检验的临床价值分析[J].医学信息,2018,31(01):151.[doi:10.3969/j.issn.1006-1959.2018.01.059]
　LIU De-fu.Clinical Value Analysis of Mycobacterium tuberculosis in Sputum of Patients with Pulmonary Tuberculosis[J].Journal of Medical Information,2018,31(03):151.[doi:10.3969/j.issn.1006-1959.2018.01.059]
[2]马 萌.健康咨询服务对肺结核知识知晓率的影响分析[J].医学信息,2018,31(06):160.[doi:10.3969/j.issn.1006-1959.2018.06.057]
　MA Meng.Analysis of the Influence of Health Counseling Service on Knowledge Awareness Rate of Pulmonary Tuberculosis[J].Journal of Medical Information,2018,31(03):160.[doi:10.3969/j.issn.1006-1959.2018.06.057]
[3]徐 伦.2010-2020年大连金普新区肺结核流行病学调查分析[J].医学信息,2022,35(09):14.[doi:10.3969/j.issn.1006-1959.2022.09.004]
　XU Lun.Epidemiological Survey of Pulmonary Tuberculosis in Jinpu New District of Dalian from 2010 to 2020[J].Journal of Medical Information,2022,35(03):14.[doi:10.3969/j.issn.1006-1959.2022.09.004]
[4]艾苗苗.肺结核的发病现状及有效预防控制策略分析[J].医学信息,2018,31(16):90.[doi:10.3969/j.issn.1006-1959.2018.16.026]
　AI Miao-miao.Analysis of the Current Situation of Tuberculosis and Effective Prevention and Control Strategy[J].Journal of Medical Information,2018,31(03):90.[doi:10.3969/j.issn.1006-1959.2018.16.026]
[5]刘 杰.静脉注射利福平治疗老年肺结核的疗效[J].医学信息,2019,32(18):142.[doi:10.3969/j.issn.1006-1959.2019.18.048]
　LIU Jie.Efficacy of Intravenous Rifampicin in the Treatment of Senile Pulmonary Tuberculosis[J].Journal of Medical Information,2019,32(03):142.[doi:10.3969/j.issn.1006-1959.2019.18.048]
[6]肖 勇,欧富华,况 杰.2013~2017年南昌市学生肺结核流行特征及防制措施[J].医学信息,2019,32(20):116.[doi:10.3969/j.issn.1006-1959.2019.20.035]
　XIAO Yong,OU Fu-hua,KUANG Jie.Epidemiological Characteristics and Control Measures of Tuberculosis among Students in Nanchang City from 2013 to 2017[J].Journal of Medical Information,2019,32(03):116.[doi:10.3969/j.issn.1006-1959.2019.20.035]
[7]宋国锋.降钙素原检测诊断肺结核合并肺部细菌感染的价值[J].医学信息,2020,33(02):179.[doi:10.3969/j.issn.1006-1959.2020.02.058]
　SONG Guo-feng.Value of Procalcitonin Detection in Diagnosis of Pulmonary Tuberculosis with Pulmonary Bacterial Infection[J].Journal of Medical Information,2020,33(03):179.[doi:10.3969/j.issn.1006-1959.2020.02.058]
[8]丁 媛.PCT及CPR鉴别社区获得性肺炎和肺结核诊断的价值[J].医学信息,2020,33(03):173.[doi:10.3969/j.issn.1006-1959.2020.03.058]
　DING Yuan.Value of PCT and CPR in the Diagnosis of Community-acquired Pneumonia and Tuberculosis[J].Journal of Medical Information,2020,33(03):173.[doi:10.3969/j.issn.1006-1959.2020.03.058]
[9]丁 媛.血清ADA水平和T-spot.TB联合检测在肺结核诊断中的应用[J].医学信息,2020,33(05):171.[doi:10.3969/j.issn.1006-1959.2020.05.058]
　DING Yuan.Application of Combined Detection of Serum ADA Level and T-spot.TB in Diagnosis of Tuberculosis[J].Journal of Medical Information,2020,33(03):171.[doi:10.3969/j.issn.1006-1959.2020.05.058]
[10]徐彩玲,苏丽洁,孙 娜,等.肺结核患者家庭密切接触者情绪变化及其影响因素分析[J].医学信息,2020,33(05):133.[doi:10.3969/j.issn.1006-1959.2020.05.042]
　XU Cai-ling,SU Li-jie,SUN Na,et al.Analysis of Emotional Changes and Influencing Factors in Close Family Contacts of Tuberculosis Patients[J].Journal of Medical Information,2020,33(03):133.[doi:10.3969/j.issn.1006-1959.2020.05.042]

更新日期/Last Update: 2019-02-25